References
- Tsamesidis I, Fozza C, Vagdatli E, et al. Total antioxidant capacity in Mediterranean β-thalassemic patients. Adv Clin Exp Med. 2017;26(5):789–793. doi: 10.17219/acem/63746
- Globin gene service HbVar registry system. Accessed 11 Nov 2023. https://globin.bx.psu.edu/cgi-bin/hbvar/counter
- Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(9):a011692. doi: 10.1101/cshperspect.a011692
- WHO-Regional desk review of haemoglobinopathies with an emphasis on thalassaemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage. Accessed 15 May 2022. https://www.who.int/publications/i/item/9789290228516.
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86:480–487. doi: 10.2471/BLT.06.036673
- Kutlar F. Diagnostic approach to hemoglobinopathies. Hemoglobin. 2007;31(2):243–250. doi: 10.1080/03630260701297071
- Hemoglobinopathy Control Program [Internet]. T.R. Ministry of Health, General Directorate of Public Health, Department of Child and Adolescent Health. 2020 Accessed 15 May 2022. Available from: https://hsgm.saglik.gov.tr/tr/tarama-programlari/hemoglobinopati-kontrol-programi.html
- Scalone L, Mantovani LG, Krol M, et al. Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin. 2008;24:1905–1917. doi: 10.1185/03007990802160834
- AlDeen N R, Osman AA, Alhabashi MJ, et al. The prevalence of β-thalassemia and other hemoglobinopathies in Kuwaiti premarital screening program: an 11-year experience. J Pers Med. 2021;11(10):980. doi: 10.3390/jpm11100980
- Canatan D, Kose MR, Ustundağ M, et al. Hemoglobinopathy control program in Turkey. Community Genet. 2006;9(2):124–126. doi: 10.1159/000091493
- Turkish Statistical Institute. Accessed 25 Jul 2022. Available from: https://data.tuik.gov.tr/Bulten/Index?p=Adrese-Dayali-Nufus-Kayit-Sistemi-Sonuclari-2020-37210#:~:text=T%C3%9C%C4%B0K%20Kurumsal&text=T%C3%BCrkiye’de%20ikamet%20eden%20n%C3%BCfus,698%20bin%20377%20ki%C5%9Fi%20oldu.
- Hemoglobinopathy Diagnostic Guide. T.R. Ministry of Health, Public Health Agency of Turkey, Vice Presidency of Consumer and Employee Safety, Department of Public Health Laboratories. https://hsgm.saglik.gov.tr/depo/birimler/tuketici-guvenligi-halk-sagligi-lab-db/Rehberler/Hemoglobinopati_Tani_Rehberi.pdf. Accessed 15 Nov 2022.
- Erten M. Premarital screening test results for beta thalassemia in Malatya province. Med Sci Int Med J. 2021;10(3):873. doi: 10.5455/medscience.2021.03.090
- Basan NM, Bilir N. Koruyucu sağlık hizmetlerinde önleme çelişkisi ve nedenleri. TAF Prev Med Bull. 2016;15(1):44. doi: 10.5455/pmb.1-1427871712
- Canatan D, Delibas S. Report on Ten ”>ten years’ experience of premarital hemoglobinopathy screening at a center in Antalya, Southern Turkey. Hemoglobin. 2016;40(4):273–276. doi: 10.3109/03630269.2016.1170030
- Oktay G. The results of hemoglobinopathy screening in Hatay, the southern part of Turkey. J Clin Anal Med. 2016;7:6–9.
- Tosun F, Bilgin A, Kizilok A, et al. Five-year evaluation of premarital screening program for hemoglobinopathies in the province of Mersin, Turkey. Turk J Haematol. 2006;23:84–89.
- Ulutas KT, Sahpaz F, Sarici IS, et al. Premarital hemoglobinopathy screening study: is Kadirli prevalent thalassemia area of Turkey? Turk J Bioch. 2014;39(3):357–361. doi: 10.5505/tjb.2014.90217
- Guler E, Garipardic M, Dalkiran T, et al. Premarital screening test results for β-thalassemia and sickle cell anemia trait in East Mediterranean region of Turkey. Pediatr Hematol Oncol. 2010;27(8):608–613. doi: 10.3109/08880018.2010.503772
- Genc A, Tastemir Korkmaz D, Buyukleyla M, et al. Prevalence and molecular analysis of β-thalassemia in Adiyaman, Turkey. Hemoglobin. 2012;36(2):131–138. doi: 10.3109/03630269.2012.658128
- Acemoglu H, Beyhun NE, Vancelik S, et al. Thalassaemia screening in a non-prevalent region of a prevalent country (Turkey): is it necessary? Public Health. 2008;122(6):620–624. doi: 10.1016/j.puhe.2007.09.007
- Guler E, Karacan M. Prevalence of beta-thalassemia and sickle cell anemia trait in premarital screening in Konya Urban Area, Turkey. Hematol Oncol. 2007;29(11):783–785. doi: 10.1097/MPH.0b013e318159a570
- Karakukcu C, Kocer D, Altuner Torun Y, et al. Premarital hemoglobinopathy screening in Kayseri. J Pediatr Hematol Oncol. 2012;34(2):e49–52. doi: 10.1097/MPH.0b013e3182370bdf
- Sarper N, Senkal V, Guray F, et al. Premarital hemoglobinopathy screening in Kocaeli, Turkey: a crowded industrial center on the north coast of Marmara Sea. Turkish J Hematol. 2009;26:62–66.
- Uysal A, Genc A, Tasyurek N, et al. Prevalence of β-thalassemia trait and abnormal hemoglobin in premarital screening in the province of Izmir, Turkey. Pediatr Hematol Oncol. 2013;30(1):46–50. doi: 10.3109/08880018.2012.742604
- Keskin A, Türk T, Polat A, et al. Premarital screening of beta-thalassemia trait in the province of Denizli, Turkey. Acta Haematol. 2000;104(1):31–33. doi: 10.1159/000041066
- Altikat S, Kuru HI, Gunay R, et al. Prevalence of β-thalassemia trait in Kutahya: a city in the eastern part of Aegean region in Turkey. SAS J Med. 2016;2:1–4.
- Akağaç EA, Soycan M, Can G, et al. Prevalence of beta thalassemia carriers in Usak province and surrounding areas. J Turkish Clin Biochem. 2019;17:36–41.
- Ministry of Internal Affairs, Directorate of Migration Management. Accessed 15 May 2022. https://www.goc.gov.tr/ikamet-genel-bilgiler
- Tan E. The long-term impact of COVID-19 lockdowns in Istanbul. Int J Environ Res Public Health. 2022 Oct 31;19(21):14235. doi: 10.3390/ijerph192114235
- Gosadi IM, Gohal GA, Dalak AE, et al. Assessment of factors associated with the effectiveness of premarital screening for hemoglobinopathies in the south of Saudi Arabia. Int J Gen Med. 2021;14:3079–3086. doi: 10.2147/IJGM.S321046
- Unver S, Işcan G, Yıldırım Bas F. Analysis of the premarital health examinations results of family physicians in Isparta: a retrospective study. J Contemp Med. 2022;12(5):699–704. doi: 10.16899/jcm.1151201